Prognostic value of PLR in various cancers: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Prognostic value of PLR in various cancers: a meta-analysis.

Prognostic value of PLR in various cancers: a meta-analysis.

http://www.wikidata.org/entity/Q33812584

about

Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysis Preoperative platelet to lymphocyte and neutrophil to lymphocyte ratios are independent prognostic factors for patients undergoing lung cancer radical surgery: A single institutional cohort study.Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer.The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy.Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study.Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis.Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy.Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib.Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma.Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort.Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.Prognostic value of inflammation-based scores in patients with osteosarcoma.Cancer and Thrombosis: The Platelet Perspective.Neutrophil-to-lymphocyte ratio is effective prognostic indicator for post-amputation patients with critical limb ischemia.Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer.A retrospective evaluation of associations between chronic obstructive pulmonary disease, smoking, and efficacy of chemotherapy and selected laboratory parameters in patients with advanced non-small cell lung cancer.Causes of variation in the neutrophil-lymphocyte and platelet-lymphocyte ratios: a twin-family study.The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer.Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancer.Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.Prognostic Role of the Pretreatment C-Reactive Protein/Albumin Ratio in Solid Cancers: A Meta-Analysis.

P2860

Q33572643-D67EC400-89A5-4EA0-9237-6DFB61BAFBAE Q33627043-99A3270E-A1C2-42BB-9C65-31C57EA0FAA8 Q33677891-399EBF37-F759-4CD1-BD3B-193D3DDF06E8 Q33762117-B5362989-5DAF-4028-99FE-A6524CAA6C33 Q33765560-FC4FC0D5-C3C6-46BE-B7D2-23C1C3292C8C Q33798830-ED5C14DD-D5AA-4A8A-AC56-4E3889D7EC5F Q35114617-13810A07-6A10-4F5B-87E7-5EEE9053CE22 Q35663441-B8DEADD5-7635-48F0-9F8B-A75414510E7D Q35672819-1D4C9881-7B20-4B70-9A48-27A0E0095476 Q35677849-57818CE9-7235-4E7D-BEA6-0262819EEDBC Q35692328-53FDF1E1-F37A-4CA9-854F-CA6F46D860F1 Q35791350-AF77D9F5-9132-47EF-AD22-85642A06EA26 Q36028749-7F383591-E309-4E78-864F-6D6A29F1926A Q36120745-CAE70CCD-8B70-41BD-8AEB-E1A07753F3FB Q36141476-B912986F-81C5-4288-9A3A-D0FB5CCE4466 Q36147745-57D5723B-239B-4DD8-A725-C0E9AE3CC0DC Q36241124-BDBD3B11-518C-4030-9F0C-52F88C634318 Q36275246-1A565FD1-9BBA-46FA-8066-FD3A10272946 Q36666680-45D7B38A-5639-43B5-8643-DDA32979E5C7 Q36666694-8CA1722F-FD40-4283-B80A-255DD60702EB Q36967771-2AB258B6-2E35-4890-920B-C07D353A17FD Q37063842-9176C66C-8298-44E5-9472-024F809DB775 Q37089422-01C40383-7426-47A7-8410-82B924D11CEB Q37129614-0AC75F97-ACF9-4212-8689-4D438C5B0561 Q37152525-C72CAB5A-833D-4AF5-B837-6406DC508610 Q37152914-EFA3232D-71FE-4AFD-9D95-488E28B80578 Q37295401-53089875-214C-44BD-8BB4-FA5B3686A389 Q37310842-A81CA038-8F60-49A6-85F9-82ED9D0AEF6F Q37406761-DBF635CA-07EF-483E-8D40-6C647F1B8E36 Q37529300-A3A8E311-E586-45C9-AE5A-81DA2DBC909D Q37558436-D470B2E3-1E72-4E17-AE07-AA6D6E494C77 Q37611903-B8306240-0959-4E29-82A2-05199CEB24A7 Q37657622-9B795112-B02D-491F-B696-7F2230D1C5F6 Q37706341-C51302F1-BEE6-4FAD-94D1-9F6155B03C7A Q37727663-5CE3C7DD-00CD-40C4-9AE0-548E0BBD7906 Q38377017-FDEE4E78-4D50-4A1C-92D5-974C761DA1E8 Q38750652-3A18BC9C-00A1-4CE3-9EAC-536116827675 Q38831513-76CB3BCC-528C-4623-8060-3EA219C1CAA5 Q38901921-6E462082-20EA-44E8-8979-73EA4F9AABF0 Q38995892-4A043522-E754-454D-8CD8-8D3D55B1E2C3

P2860

Prognostic value of PLR in various cancers: a meta-analysis.

http://www.wikidata.org/entity/Q33812584

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prognostic value of PLR in various cancers: a meta-analysis.

@ast

Prognostic value of PLR in various cancers: a meta-analysis.

@en

type

label

Prognostic value of PLR in various cancers: a meta-analysis.

@ast

Prognostic value of PLR in various cancers: a meta-analysis.

@en

prefLabel

Prognostic value of PLR in various cancers: a meta-analysis.

@ast

Prognostic value of PLR in various cancers: a meta-analysis.

@en

P1433

Q33812584-326F7DD2-75D5-4964-B91B-93F483F33EB2

P1476

Q33812584-6C62275A-BBCF-4B36-9BFB-4AF927E07DF0

P2093

Q33812584-150E2083-2E20-41F8-BB99-80EA58890266

Q33812584-47C7ABF8-5F39-42A3-B701-89FDC1F63902

Q33812584-5E16B4C4-C870-4A81-93E9-50664443D2FC

Q33812584-6ABA15C4-D06A-43D3-B5F5-C1C6E18A5C35

Q33812584-74B0BE78-3EAA-45CE-88C1-AB8FC717D076

Q33812584-7CEBF60D-8CC7-49BF-935A-F6093DCBC7AE

Q33812584-96F4A496-7C64-4AF7-A652-B2FED1DD38F2

Q33812584-BA85AC5E-CEE8-4EEF-994E-44A864E3479F

Q33812584-F1BC3A92-26CB-4534-829D-4E3D7805CD2F

P2860

Q33812584-092BEBA9-8483-4961-952D-3C4B76684DB9

Q33812584-0BDE0E33-D1C0-4137-8E2A-155086CBCF12

Q33812584-150ECBB5-181A-44B3-AD80-9BEF08F75F86

Q33812584-1846A5F9-0AEA-4414-86ED-051F44897D45

Q33812584-1AA3B3ED-DC11-4016-A4D8-DA00900D7152

Q33812584-1C696C14-2BEA-494B-B5E1-35F1C54D7500

Q33812584-1E9154EE-E2C9-4E40-AEEE-0B29406B68C2

Q33812584-20762AF7-CE82-4F8E-BC5C-B3103B27E4FE

Q33812584-2E6CC4A0-3729-4B72-A1E4-B1ECC6528A65

Q33812584-368C3288-0CF2-48F1-88B3-33AEE5A1883C

P304

Q33812584-4F3E132A-3D4D-493B-8B74-92E146A5E2E8

P31

Q33812584-4fb99f6e-e7b3-468c-aa87-ddd4de240e9c

Q33812584-86CE3FEB-8D8A-494F-9467-76C98B3DA5BC

P356

Q33812584-CD491514-D7D0-44C9-B79D-B1AE80E67E9B

P407

Q33812584-74FD63EB-5BAD-4BDD-9DFC-41C65B405CE8

P433

Q33812584-5656251F-712B-4988-9FE2-96051F41598D

P478

Q33812584-4B8754EF-BD6E-42DE-B0DB-8ED9A55BFD66

P577

Q33812584-445FBF77-7C9D-4362-8B71-E13F623EFA9B

P5875

Q33812584-09CBBD93-D201-4BBF-BE01-36EEFEA4F269

P698

Q33812584-5B843020-D8BA-449A-9028-3B0C49C47771

P932

Q33812584-5007A6AB-0E02-4195-8306-F2FD4B346F37

P356

JOURNAL.PONE.0101119

P1433

P1476

Prognostic value of PLR in various cancers: a meta-analysis.

@en

P2093

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Jun Xu

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Tianzhu Qiu

http://www.w3.org/2001/XMLSchema#string

Tongshan Wang

http://www.w3.org/2001/XMLSchema#string

Wei Zhu

http://www.w3.org/2001/XMLSchema#string

Xin Zhou

http://www.w3.org/2001/XMLSchema#string

Yiping Du

http://www.w3.org/2001/XMLSchema#string

Zebo Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

Hallmarks of Cancer: The Next Generation

Cancer regression in patients after transfer of genetically engineered lymphocytes

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Cancer statistics, 2013

Meta-analysis in clinical trials

Cancer-related inflammation

Statistical aspects of the analysis of data from retrospective studies of disease

Immunity, Inflammation, and Cancer

P304

e101119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0101119

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263476450

http://www.w3.org/2001/XMLSchema#string

P698

24968121

http://www.w3.org/2001/XMLSchema#string

P932

4072728

http://www.w3.org/2001/XMLSchema#string